Online Consultation For Targeted Therapy Doctors in India

Targeted Therapy is an advanced cancer treatment that uses drugs or biologics to precisely attack cancer cells by interfering with specific molecular targets. It's commonly used in lung, breast, colon, leukaemia, and lymphoma cancers. Choosing the right oncologist ensures optimal drug selection, genetic testing, response monitoring, and minimal side effects.

Outcomes improve when treatment is delivered at hospitals with dedicated medical oncology teams, access to genetic diagnostics, and availability of targeted drug regimens.

• JCI or NABH-accredited cancer care centers
• Dedicated molecular oncology and genetic profiling labs
• Access to FDA/EMA-approved targeted therapy drugs
• Integrated tumor boards for treatment planning
• Onco-pharmacy with drug sourcing and dosing precision
• Comprehensive supportive care (nutrition, infection control)

Yes. MediGence allows you to consult cancer specialists virtually for diagnosis review, genomic eligibility, and personalised therapy planning.

• Share histopathology reports, biopsy results, or imaging (CT/MRI/PET)
• Upload prior treatment history (chemo/radiation/surgery)
• Include genetic test results (e.g., EGFR, HER2, ALK, BRCA, PD-L1)
• Mention symptoms, side effects, concerns, and cancer stage

Targeted therapy is mostly outpatient-based and involves periodic hospital visits.

• Evaluation & Genomic Testing: 3–5 days
• Initial Therapy Administration & Monitoring: 2–3 days
• Response Monitoring & Dosing Adjustment: Weekly or biweekly follow-ups (can be virtual)
• Follow-up and Side Effect Management: 3–5 days if needed

Total Initial Stay: 1–2 weeks; continued therapy can be planned remotely or over repeat visits.

Yes. MediGence helps you receive second opinions for:

• Confirming if targeted therapy is suitable for your cancer type
• Choosing between multiple targeted drugs
• Deciding between monotherapy or combination (with immunotherapy/chemotherapy)
• Understanding side effects, resistance potential, and success rates

Absolutely. India is a global leader in precision oncology with skilled specialists and affordable access to the latest FDA/EMA-approved therapies.

• Oncologists trained in the US/UK with targeted therapy expertise
• Cost-effective treatment options (30–70% lower than Western countries)
• Full access to international drug formulations
• Molecular diagnostics and real-time monitoring tools are available
• Personalised plans with supportive care and English-speaking teams

• Online consultation and eligibility screening
• Genetic testing coordination
• Visa, travel, and accommodation assistance
• Oncology nurse support and follow-up reminders
• Drug sourcing and pharmacy assistance

• MD (Internal Medicine) or DNB
• DM (Medical Oncology) or Fellowship in Oncology
• Experience in molecular oncology and drug targeting protocols

• 10–20+ years in solid tumors or hematologic cancers
• Proficient in interpreting genetic mutation reports
• Experienced in managing targeted drug interactions and toxicities
• Familiar with resistance pathways and second-line therapies

Yes. Often, targeted therapy is combined for optimal results:

• With Immunotherapy (e.g., checkpoint inhibitors)
• Alongside Chemotherapy or Hormone Therapy
• Post Surgery or Radiotherapy for residual disease
• Integrated with Bone Marrow Transplant in hematological malignancies
• With palliative care to manage symptoms and improve life quality

• JCI/NABH accreditation
• Oncologist trained in molecular or precision oncology
• Availability of international oncology drugs
• Transparent drug cost and therapy schedule
• Genetic lab partnerships and test turnaround
• Verified patient success stories, reviews, or survival outcomes

• Oncologist evaluates cancer stage, mutation markers, and therapy line
• Recommends ideal targeted drug(s) and dosage
• Reviews benefits, potential side effects, and response timelines
• Discusses cost, drug availability, and follow-up plan
• Prepares written plan and quotation for visa/travel assistance